Benzinga's Volume Movers (GXDX, CLDA, HUGH, LPHI)

Genoptix Inc GXDX shares moved up 25.76% to $24.85 at 10:46 am. The volume of GXDX shares traded was 12456% higher than normal. Novartis AG NVS announced its plans to buy GXDX for $470 million, or $25 per share, representing a 39% premium over GXDX's share value on December 13, 2010. Clinical Data Inc CLDA shares rose 58.15% to $23.77. The volume of CLDA shares traded was 8137% higher than normal. The Food and Drug Administration (FDA) approved the CLDA's depression drug Viibryd. Hughes Communications Inc HUGH shares climbed 2.90% to $62.62. The volume of HUGH shares traded was 271% higher than normal. According to a Reuters report, HUGH has put itself up for sale. Life Partners Holdings Inc LPHI shares gained 8.80% to $12.86. The volume of LPHI shares traded was 261% higher than normal. LPHI has a dividend yield of 8.50%. Read more from Benzinga's Markets.